SCHEMBL7621632

SCHEMBL7621632

O=C1c2ccccc2CN2C(=O)CCC12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 3/20 0.51
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ACHE P22303 2/20 0.40
CYP19A1 P11511 1/20 0.39
NOTUM Q6P988 1/20 0.38
CYP2A6 P11509 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
METAP1 P53582 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CHRM2 P08172 1/20 0.37
OPRM1 P35372 1/20 0.37
DDB1 Q16531 1/20 0.37
IKZF3 Q9UKT9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10378790 0.80 CRBN (0.46) CRBNKMT2AALDH1A1ACHECYP19A1
SCHEMBL7616399 0.80 CRBN (0.46) CRBNKMT2AALDH1A1KDM4EMAPT
SCHEMBL10378789 0.80 CRBN (0.46) CRBNKMT2AALDH1A1ACHECYP19A1
SCHEMBL7627822 0.80 CRBN (0.46) CRBNKMT2AALDH1A1KDM4EMAPT
SCHEMBL10671026 0.78 NOTUM (0.40) CRBNNOTUM
SCHEMBL10692994 0.78 SRD5A1 (0.41) CRBNACHEMETAP1RAB9A
SCHEMBL10674343 0.78 SRD5A1 (0.40) CRBNALDH1A1ACHERAB9ADDB1
SCHEMBL10687019 0.78 CRBN (0.40) CRBNHDAC1HDAC6METAP1DDB1
SCHEMBL10377619 0.78 NOTUM (0.43) CRBNNOTUMMETAP1
SCHEMBL10377620 0.75 CRBN (0.40) CRBNALDH1A1KDM4EMAPTHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436954-B1 BENZO(B)QUINOLIZIDINE AND BENZO(F)INDOLIZIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE, SENILE DEMENTIA OR OTHER CONDITIONS CHARACTERIZED BY MEMORY LOSS; PYRROLO(1,2-B)ISOQUINOLINES, BENZO(B)QUINOLIZINES AMERICAN BIOGENETIC SCIENCES, INC. 2002-08-20 US disclosed
EP-1098650-A1 BENZOQUINOLIZIDINE AND BENZOINDOLIZIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AMERICAN BIOGENETIC SCIENCES, INC. (US) 2001-05-16 EP disclosed
WO-2000004905-A1 BENZOQUINOLIZIDINE AND BENZOINDOLIZIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AMERICAN BIOGENETIC SCIENCES, INC. (US) 2000-02-03 WO disclosed
EP-0197318-B1 Benzo[C]-1,5-naphthyridines, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1990-05-09 EP disclosed
US-4742171-A AROMATIZATION, REARRANGEMENT HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-05-03 US disclosed
US-4742061-A Benzoc[c]-1,5-naphthyridines and related compounds as memory enhancing agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-05-03 US disclosed
US-4670562-A MEMORY ENHANCEMENT HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-06-02 US disclosed
US-4652567-A Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-03-24 US disclosed